Proadifen hydrochloride

Overview

Proadifen (SKF-525A) hydrochloride is a non-competitive Cytochrome P450 inhibitor with an IC 50 value of 19 μM. Proadifen hydrochloride reduces monoamine oxidase A ( MAO-A ) activity and reverses the antidepressantlike behavioral effect of Imipramine ( HY-B1490A ) and Desipramine ( HY-B1272A ) in rats. Proadifen hydrochloride also reduces N, N-dimethyltryptamine ( DMT ) metabolism in liver microsomes and inhibits N-demethylationand Acridone ( HY-W007771 ) formation. Proadifen hydrochloride augments Lipopolysaccharide (LPS) ( HY-D1056 )-induced fever and exacerbates Prostaglandin E2 (PGE2) ( HY-101952 ) levels in the rat. Proadifen hydrochloride is promising for research of metabolism-related deseases, ovarian carcinoma, inflammation and dopamine neurons-related deseases.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Survivin | Products > Signaling Pathways > PARP | Products > Signaling Pathways > Cytochrome P450 | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Bcl-2 Family

Product Information

• Catalog No.: HY-B1311
• CAS No.: 62-68-0
• Molecular Formula: C23H32ClNO2
• Molecular Weight: 389.96
• Purity: 99.95%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.08 mg/mL (5.33 mM); Clear solution
• Availability: In-stock

Source

Original product source